Alan Lankester
National Blood Service
12 Papers
261 Citations
Alan Lankester is an academic researcher from National Blood Service. The author has contributed to research in topics: Transplantation & ISBT 128. The author has an hindex of 8, co-authored 12 publications.
Chat about Author
Papers
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia.
C. J. C. Knechtli,Nick Goulden,Jeremy Hancock,E. L. Harris,R. J. Garland,C. G. Jones,Victoria Grandage,A. W. Rowbottom,Ann Green,E Clarke,Alan Lankester,M N Potter,Jacqueline M. Cornish,Derwood Pamphilon,Colin G. Steward,A Oakhill +15 more
TL;DR: If immunotherapy were to be targeted towards patients with evidence of persisting MRD after allogeneic bone marrow transplantation (allo-BMT), the method described would expose only a small proportion of patients to unnecessary additional toxicity.
108
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.
Ann Green,Emer Clarke,Linda P. Hunt,Andrew Canterbury,Alan Lankester,Geoff Hale,Herman Waldmann,Sally Goodman,Jacqueline M. Cornish,David I. Marks,Colin G. Steward,Anthony Oakhill,Derwood Pamphilon +12 more
TL;DR: Although HLA mismatching results in an increased occurrence of primary graft failure with T-cell-depleted allografts, it allows more donors to be identified rapidly for children with ALL without compromising overall transplant outcome.
80
Directed sibling cord blood banking for transplantation: the 10-year experience in the national blood service in England.
Jon Smythe,S. Armitage,Dorothy McDonald,Derwood Pamphilon,Martin Guttridge,Juliette Brown,A Green,Colin Brown,Ruth Warwick,Alan Lankester,D. Fehily,M. Contreras,Cristina Navarrete,Cristina Navarrete,Suzanne M. Watt,Suzanne M. Watt +15 more
TL;DR: The procedures that the National Blood Service has used for DCB donations, the outcome data where donations have been used for transplantation, and it provides some timely recommendations for best practices are detailed.
57
Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback.
Suparno Chakrabarti,J Brown,Martin G Guttridge,Derwood Pamphilon,Alan Lankester,David I. Marks +5 more
TL;DR: TCAB with a CD34+ selected graft resulted in a comparable outcome in both older and younger patients, but the survival was strongly influenced by early lymphocyte recovery.
46
Standards for the Terminology and Labeling of Cellular Therapy Products
Paul Ashford,Pat Distler,Adrian P. Gee,Alan Lankester,Stella Larsson,Irene Feller,Kathy Loper,Derwood Pamphilon,Leigh Poston,Fran Rabe,Ineke Slaper-Cortenbach,Zbigniew M. Szczepiorkowski,Phyllis I. Warkentin +12 more
TL;DR: The labeling standard, supported by the ISBT 128 information system, will ensure unique global identification of cellular therapy products, an international reference table for product descriptions, and label design that is consistent worldwide.
16